Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Kristensen

Showing results (141-150 of 320) with videos related to

Pageof 32
Sort By:
Brain, Behavior, and Immunity|April 19, 2011
Fatigued breast cancer survivors and gene polymorphisms in the inflammatory pathwayKristin V Reinertsen, Grethe I Grenaker Alnæs, Hege Landmark-Høyvik, et al.
Scientific Reports|May 26, 2021
MicroRNA in combination with HER2-targeting drugs reduces breast cancer cell viability in vitroLisa Svartdal Normann, Miriam Ragle Aure, Suvi-Katri Leivonen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 9, 2014
DNA methylation status of key cell-cycle regulators such as CDKNA2/p16 and CCNA1 correlates with treatment response to doxorubicin and 5-fluorouracil in locally advanced breast tumorsJovana Klajic, Florence Busato, Hege Edvardsen, et al.
Clinical Epigenetics|July 28, 2015
DNA methylation in ductal carcinoma in situ related with future development of invasive breast cancerKevin C Johnson, Devin C Koestler, Thomas Fleischer, et al.
Genes, Chromosomes & Cancer|April 10, 2008
Genome-wide analysis identifies 16q deletion associated with survival, molecular subtypes, mRNA expression, and germline haplotypes in breast cancer patientsSilje H Nordgard, Fredrik E Johansen, Grethe I G Alnaes, et al.
Molecular Oncology|January 12, 2010
Glycan gene expression signatures in normal and malignant breast tissue; possible role in diagnosis and progressionIvan O Potapenko, Vilde D Haakensen, Torben Lüders, et al.
BMC Cancer|March 21, 2014
Systematic assessment of prognostic gene signatures for breast cancer shows distinct influence of time and ER statusXi Zhao, Einar Andreas Rødland, Therese Sørlie, et al.
Breast Cancer Research : BCR|April 18, 2001
Low frequency of E-cadherin alterations in familial breast cancerS Salahshor, L Haixin, H Huo, et al.
Cell Systems|January 28, 2019
A Computational Framework for Genome-wide Characterization of the Human Disease LandscapeYoung-Suk Lee, Arjun Krishnan, Rose Oughtred, et al.
Nucleic Acids Research|December 8, 2022
Cis-regulatory mutations associate with transcriptional and post-transcriptional deregulation of gene regulatory programs in cancersJaime A Castro-Mondragon, Miriam Ragle Aure, Ole Christian Lingjærde, et al.
Pageof 32

Showing results (141-150 of 320) with videos related to

Sort By:
Pageof 32
Brain, Behavior, and Immunity|April 19, 2011
Fatigued breast cancer survivors and gene polymorphisms in the inflammatory pathwayKristin V Reinertsen, Grethe I Grenaker Alnæs, Hege Landmark-Høyvik, et al.
Scientific Reports|May 26, 2021
MicroRNA in combination with HER2-targeting drugs reduces breast cancer cell viability in vitroLisa Svartdal Normann, Miriam Ragle Aure, Suvi-Katri Leivonen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 9, 2014
DNA methylation status of key cell-cycle regulators such as CDKNA2/p16 and CCNA1 correlates with treatment response to doxorubicin and 5-fluorouracil in locally advanced breast tumorsJovana Klajic, Florence Busato, Hege Edvardsen, et al.
Clinical Epigenetics|July 28, 2015
DNA methylation in ductal carcinoma in situ related with future development of invasive breast cancerKevin C Johnson, Devin C Koestler, Thomas Fleischer, et al.
Genes, Chromosomes & Cancer|April 10, 2008
Genome-wide analysis identifies 16q deletion associated with survival, molecular subtypes, mRNA expression, and germline haplotypes in breast cancer patientsSilje H Nordgard, Fredrik E Johansen, Grethe I G Alnaes, et al.
Molecular Oncology|January 12, 2010
Glycan gene expression signatures in normal and malignant breast tissue; possible role in diagnosis and progressionIvan O Potapenko, Vilde D Haakensen, Torben Lüders, et al.
BMC Cancer|March 21, 2014
Systematic assessment of prognostic gene signatures for breast cancer shows distinct influence of time and ER statusXi Zhao, Einar Andreas Rødland, Therese Sørlie, et al.
Breast Cancer Research : BCR|April 18, 2001
Low frequency of E-cadherin alterations in familial breast cancerS Salahshor, L Haixin, H Huo, et al.
Cell Systems|January 28, 2019
A Computational Framework for Genome-wide Characterization of the Human Disease LandscapeYoung-Suk Lee, Arjun Krishnan, Rose Oughtred, et al.
Nucleic Acids Research|December 8, 2022
Cis-regulatory mutations associate with transcriptional and post-transcriptional deregulation of gene regulatory programs in cancersJaime A Castro-Mondragon, Miriam Ragle Aure, Ole Christian Lingjærde, et al.
Pageof 32